A systematic evidence map of chronic inflammation and immunosuppression related to per- and polyfluoroalkyl substance (PFAS) exposure
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The ability to induce chronic inflammation and immunosuppression are two key characteristics of carcinogens and important forms of immunotoxicity. The National Toxicology Program (NTP) evaluated the immunotoxicity of two per- and polyfluoroalkyl substances (PFASs), PFOA (perfluorooctanoic acid) and PFOS (perfluorooctane sulfonate), in 2016. However, the potential pro-inflammatory and immunosuppressive effects of other PFASs remain largely uncharacterized. METHODS: We developed an expanded set of search terms pertaining to the chronic inflammatory and immunosuppressive effects of PFASs based on those of the International Agency for Research on Cancer (IARC) and NTP. To confirm searching effectiveness and scope, we compared our search term results with those of IARC and NTP for both PFASs and two other known carcinogens, chromium (VI) and benzene. Systematic evidence maps (SEMs) were also produced using Tableau to visualize the distribution of study numbers and types reporting immunotoxic effects and specific biomarkers elicited by PFAS exposures. RESULTS: In total, 1155 PFAS studies were retrieved, of which 321 qualified for inclusion in our dataset. Using our search terms, we identified a greater number of relevant studies than those obtained using IARC and NTP's search terms. From the SEM findings, increased cytokine production strengthened an association between PFAS exposure and chronic inflammation, and decreased B-cell activation and altered levels of T-cell subtypes and immunoglobulins confirmed PFAS-induced immunosuppression. CONCLUSION: Our SEM findings confirm that several PFASs commonly found in both in the environment, including those that are lesser-known, may induce immunosuppression and chronic inflammation, two key characteristics of carcinogens. This approach, including development of search terms, study screening process, data coding, and evidence mapping visualizations, can be applied to other key characteristics of chemical carcinogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 1×
“General biomarkers for inflammation can be attributed to both acute and chronic inflammation as both types of inflammation share a wide variety of phenotypes and biomarkers (Furman et al., 2019).”
BackgroundFujiwara, N., & Kobayashi, K. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010054022024 · Cited by 1,420 · cited 2×
“…have included any perturbation to these myeloid-lineage cell numbers as KCC6 outcomes as they are important mediators of acute inflammatory process (Fujiwara and Kobayashi, 2005), though neutrophils and macrophages have more recently been recognized as having a role in chronic inflammation as well…”
BackgroundLa Merrill, M. A., Vandenberg, L. N., Smith, M. T., Goodson, W., Browne, P., Patisaul, H. B., Guyton, K. Z., Kortenkamp, A., Cogliano, V. J., Woodruff, T. J., et al. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0273-8 · Cited by 1,005
Self-citationA methodology for systematic mapping in environmental sciences
James, K. L., Randall, N. P., & Haddaway, N. R. (2016) · Environmental Evidence · doi:10.1186/s13750-016-0059-6 · Cited by 769 · cited 2×
“We conducted this SEM project using a modification of the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) (Page et al., 2021) and guidance from James et al. (2016) and the Collaboration for Environmental Evidence (CEE, 2018).”
BackgroundMethodNeutrophils to the ROScue: Mechanisms of NADPH oxidase activation and bacterial resistance
Nguyen, G. T., Green, E. R., & Mecsas, J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00373 · Cited by 741 · cited 1×
“…(e.g. IL-1 β , IL-6, and TNF-α , as supported by the SEM herein (Section 3.4, Table 4)) which chemically attract other inflammatory cells (i.e. neutrophils) to the site, where they then generate and release large amounts of reactive oxygen species (ROS) following activation (Nguyen et al., 2017).”
BackgroundInfluentialCordner, A., De La Rosa, V. Y., Schaider, L. A., Rudel, R. A., Richter, L., & Brown, P. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0099-9 · Cited by 363 · cited 1×
“…several developed nations) and new PFASs (emerging short-chain alternatives to older technologies), have been detected not only in drinking water (Cordner et al., 2019), atmospheric particles (Lin et al., 2020), juvenile seabirds (with levels of PFOS being the highest) (Robuck et al., 2020) and…”
BackgroundGranum, B., Haug, L. S., Namork, E., Stølevik, S. B., Thomsen, C., Aaberge, I. S., van Loveren, H., Løvik, M., & Nygaard, U. C. (2013) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.755580 · Cited by 339 · cited 2×
“Endpoints directly related to immunosuppression, such as increased risk of infectious diseases (WHO, 2012), have also been linked to PFAS exposures (Ait Bamai et al., 2020; Granum et al., 2013).”
BackgroundSzilagyi, J. T., Avula, V., & Fry, R. C. (2020) · Current Environmental Health Reports · doi:10.1007/s40572-020-00279-0 · Cited by 328 · cited 1×
“…limited in number, these studies provide evidence that both PFOA and PFOS exposure suppressed the release of chemokines such as CXCL2, CXCL8, CXCL9, and CXCL10, as reported in various human cell lines and in a non-mammalian animal study (Sorli et al., 2020; Szilagyi, 2020; Zhang et al., 2020).”
BackgroundTargeting inflammasome/IL-1 pathways for cancer immunotherapy
Guo, B., Fu, S., Zhang, J., Liu, B., & Li, Z. (2016) · Scientific Reports · doi:10.1038/srep36107 · Cited by 302 · cited 1×
“…malignant progression in lung, breast, hepatic, skin and pancreatic cancers, pointing to the fact that the NLRP3 protein and inflammasome formation are crucial components in the development of these cancers (Chow et al., 2012a, 2012b; Daley et al., 2017; Deng et al., 2019; Guo et al., 2016).”
BackgroundNLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
Daley, D., Mani, V. R., Mohan, N., Akkad, N., Pandian, G. S. D. B., Savadkar, S., Lee, K. B., Torres-Hernandez, A., Aykut, B., Diskin, B., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161707 · Cited by 244
Severity of COVID-19 at elevated exposure to perfluorinated alkylates
Grandjean, P., Timmermann, C. A. G., Kruse, M., Nielsen, F., Vinholt, P. J., Boding, L., Heilmann, C., & Mølbak, K. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244815 · Cited by 131
Subchronic Effects of Perfluorooctanesulfonate Exposure on Inflammation in Adult Male C57BL/6 Mice
Dong, G., Zhang, Y., Zheng, L., Liang, Z., Jin, Y., & He, Q. (2012) · Environmental Toxicology · doi:10.1002/tox.20642 · Cited by 49
Cited by
Perfluoroalkyl/polyfluoroalkyl substances: Links to cardiovascular disease risk
Schlezinger, J. J., & Gokce, N. (2024) · Circulation Research · doi:10.1161/circresaha.124.323697 · Cited by 103
“142 More research is needed to define the relationship of PFAS with inflammatory activation (eg, measures of C-reactive protein and IL-1 β ) in humans.”
Dunder, L., Salihovic, S., Lind, P. M., Elmståhl, S., & Lind, L. (2023) · Environment International · doi:10.1016/j.envint.2023.107979 · Cited by 60
Du, X., Xu, X., Dong, X.-X., Liang, X., Wu, Y., Du, Z., Pan, C.-W., Liang, G., Li, Y.-Z., Zheng, Y.-J., et al. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c01138 · Cited by 24
Qiao, W., Li, J., Luo, L., Peng, W., Wang, X., Jin, R., & Li, J. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117436 · Cited by 16
Metadata
- Authors
- Zhang, L., Louie, A., Rigutto, G., Guo, H., Zhao, Y., Ahn, S., Dahlberg, S., Sholinbeck, M., & Smith, M. T.
- Venue
- Environmental Research
- Publisher
- Elsevier BV
- Published
- 2023-03
- Volume
- 220
- Pages
- 115188
- ISSN
- 0013-9351 (ISSN-L)
- OpenAlex
- W4313317656
- Cited by
- 106
- References
- 14
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.